tradingkey.logo
tradingkey.logo
Search

MiMedx Group Inc

MDXG
Add to Watchlist
4.130USD
-0.140-3.28%
Close 07-31 16:00ETQuotes delayed by 15 min
601.99MMarket Cap
19.87P/E TTM

MiMedx Group Inc

4.130
-0.140-3.28%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-3.28%

5 Days

-1.67%

1 Month

+4.56%

6 Months

-18.86%

Year to Date

-39.00%

1 Year

-42.32%

Key Figures
4.170Open
4.210High
2.99MVolume
19.87P/E TTM
36.22P/E Dynamic
--Dividend TTM
2.01%Turnover Ratio
4.270Prev. Close
3.973Low
7.76MTurnover
14.50P/E Static
2.53P/B
0.00%Div Yield TTM
10.60%ROA
7.99052wk High
1.17Volume Ratio
42.42MNet Profit
148.93MShares
0.2078EPS TTM
1.47Beta
13.77%ROE
3.02552wk Low
5.56%Amplitude
68.50%Gross Margin
601.99MMarket Cap
2.00Reward/Risk
2.46%Risk Rate

TradingKey Stock Score of MiMedx Group Inc

Currency: USD Updated: 2026-07-31

Key Insights

MiMedx Group Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 77 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.60.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

MiMedx Group Inc's Score

Industry at a Glance

Industry Ranking
77 / 385
Overall Ranking
152 / 4281
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

MiMedx Group Inc Highlights

StrengthsRisks
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 30.22% year-on-year.
Fairly Valued
The company’s latest PE is 19.87, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 116.77M shares, increasing 5.02% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 288.09K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.17.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
6.600
Target Price
+59.81%
Upside Space

MiMedx Group Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 5 analysts
Buy
Current Rating
6.600
Target Price
+59.81%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
MiMedx Group Inc
MDXG
5
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.049
Neutral
RSI(14)
50.343
Neutral
STOCH(KDJ)(9,3,3)
57.125
Neutral
ATR(14)
0.210
High Vlolatility
CCI(14)
-116.047
Sell
Williams %R
46.763
Neutral
TRIX(12,20)
0.404
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
4.250
Sell
MA10
4.240
Sell
MA20
4.223
Sell
MA50
3.919
Buy
MA100
3.858
Buy
MA200
5.060
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

MiMedx Group Inc Info

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Ticker SymbolMDXG
CompanyMiMedx Group Inc
CEOCapper (Joseph H)
Websitehttps://mimedx.com/

Shareholders

Shareholders
Shareholders
Proportion
EW Healthcare Partners
18.93%
BlackRock Institutional Trust Company, N.A.
5.90%
Trigran Investments, Inc.
4.14%
Vanguard Capital Management, LLC
3.47%
State Street Investment Management (US)
2.56%
Other
65.00%

FAQs

What is the current price of MiMedx Group Inc (MDXG)?

The current price of MiMedx Group Inc (MDXG) is 4.13.

What is the symbol of MiMedx Group Inc?

The ticker symbol of MiMedx Group Inc is MDXG.

What is the 52-week high of MiMedx Group Inc?

The 52-week high of MiMedx Group Inc is 7.99.

What is the 52-week low of MiMedx Group Inc?

The 52-week low of MiMedx Group Inc is 3.02.

What is the market capitalization of MiMedx Group Inc?

The market capitalization of MiMedx Group Inc is 601.99M.

Is MiMedx Group Inc (MDXG) currently rated as Buy, Hold, or Sell?

According to analysts, MiMedx Group Inc (MDXG) has an overall rating of Buy, with a price target of 6.60.

What is the Earnings Per Share (EPS TTM) of MiMedx Group Inc (MDXG)?

The Earnings Per Share (EPS TTM) of MiMedx Group Inc (MDXG) is 0.33.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.